Polaris Group (TWSE: 6550)
Health Care · Biotechnology · KY
NT$16.70
-0.30% today · -76.4% 1Y
Polaris Group (TWSE: 6550) operates in the Biotechnology industry within the Health Care sector. The company is valued at $242.78M and employs 83,293 people.
Over the last twelve months the share price has lost 76.4%, trading between 16.00 and 73.92.
Tweenvest scores Polaris Group across four factors: quality 39/100, value 37/100, growth 65/100. Its strongest factor is growth.
6550 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $242.78M
- Revenue (TTM)
- $2.14M
- P/E
- —
- EPS
- -8.86
- Dividend yield
- —
- Beta (5Y)
- 0.59
- 52-week high
- NT$73.92
- 52-week low
- NT$16.00
- Avg volume (3M)
- —
- Shares outstanding
- 464.85M
- Employees
- 83,293
- Next earnings
- —
About Polaris Group
Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications, as well as provides healthcare consulting, staffing, and MDS solutions. The company was incorporated in 2006 and is based in Grand Cayman, Grand Cayman.
- ISIN
- KYG7171A1085
- Founded
- 2006
- Listed since
- Feb 15, 2016
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Q32 Bio Inc.NasdaqCM: QTTB | $248.28M | $8.34 | +1.34% |
| Shandong Boan Biotechnology Co., Ltd.SEHK: 6955 | $245.84M | HK$3.10 | +2.31% |
| Acepodia, Inc.TPEX: 6976 | $244.38M | NT$13.40 | +4.69% |
| Oryzon Genomics S.A.BME: ORY | $243.20M | €2.65 | +0.76% |
| Greenwich LifeSciences, Inc.NasdaqCM: GLSI | $242.63M | $16.53 | -2.65% |
| Pyxis Oncology, Inc.NasdaqGS: PYXS | $242.50M | $2.03 | -5.14% |
| SillaJen, Inc.KOSDAQ: A215600 | $241.16M | ₩2,340.00 | -0.85% |
| MacroGenics, Inc.NasdaqGS: MGNX | $238.24M | $3.74 | +5.35% |
Figures last refreshed Oct 11, 2026.